Text Size

Pan-European survey of the topical ocular use of cyclosporine A [Utilisation de la cyclosporine A topique : une étude pan-européenne]

Labbé A., Baudouin C., Ismail D., Amrane M., Garrigue J.-S., Leonardi A., Figueiredo F.C., Van Setten G., Labetoulle M.


  • 2017
  • Journal Francais d'Ophtalmologie
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Post-Approval studies/RWE

  • Affiliations

    Department of Ophthalmology, Quinze-Vingts National Ophthalmology Hospital, Paris, France; Ambroise Paré Hospital, AP–HP, University of Versailles Saint-Quentin-en-Yvelines, Versailles, France; Santen SAS, Evry, France; Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua, Italy; Royal Victoria Infirmary, Newcastle University, Newcastle upon Tyne, United Kingdom; St. Eriks Eye Hospital, Karolinska Institute, Stockholm, Sweden; Ophthalmology Department, South Paris University, Bicêtre Hospital, AP–HP, Kermin-Bicêtre, France

Related Publications

Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study

Ishikawa H., Oka K., Inoue H.


Tear Biomarkers of Topical Sirolimus in Meibomian Gland Dysfunction: A Randomized Trial

Zhou L.; Shimizu H.; Togashi Y.; Kirihara T.; Yang Y.; Lam C.T.; Shimada H.; Tong L.


Layer-by-layer tear film measurement in patients with dry eye and meibomian gland dysfunction

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022